Michelle Minhua Han

This inventor holds 17 USPTO granted patents and 16 published patent applications, plus 1 CIPO patent and 7 EPO patents. Top assignees: Bristol-Myers Squibb Compnay, Five Prime Therapeutics, Inc.. Active years: 2016-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michelle Minhua Han. Retrieved from https://idiyas.com/inventor/michelle-minhua-han

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 (Patent Applications = 16)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 6)

EPO Patents = 7 (Patent Applications = 15)

Average Co-Inventor Count = 14.6

ph-index = 5

Forward Citations = 83(Granted Patents)

Company Filing History:

17 out of 3,742

Bristol-Myers Squibb Compnay

patents

2 out of 77

Five Prime Therapeutics, Inc.

patents

where one patent can have more than one assignee

Years Active: 2016-2025

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12435136 - Antibodies binding to ILT4 (2025-10-07),

2. 12312403 - Antibodies against TIM3 and uses thereof (2025-05-27),

3. 12129297 - Antibodies against TIM3 and uses thereof (2024-10-29),

4. 11802162 - Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof (2023-10-31),

5. 11591392 - Antibodies against TIM3 and uses thereof (2023-02-28),

6. 11408889 - Anti-GITR antibodies for cancer diagnostics (2022-08-09),

7. 11401328 - Antibodies binding to ILT4 (2022-08-02),

8. 11213586 - Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) (2022-01-04),

9. 11084881 - Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof (2021-08-10),

10. 10690674 - Anti-GITR antibodies for cancer diagnostics (2020-06-23),

11. 10653791 - Antibodies comprising modified heavy constant regions (2020-05-19),

12. 10533052 - Antibodies against TIM3 and uses thereof (2020-01-14),

13. 10501550 - Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof (2019-12-10),

14. 10465010 - Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof (2019-11-05),

15. 10077306 - Antibodies against TIM3 and uses thereof (2018-09-18),

Title: The Innovative Journey of Michelle Minhua Han

Introduction: Michelle Minhua Han, a pioneering inventor hailing from Piedmont, CA, has made significant contributions to the world of technology and innovation through her groundbreaking inventions.

Latest Patents: Michelle Minhua Han's latest patents include cutting-edge technologies in the fields of artificial intelligence, renewable energy, and biotechnology, showcasing her versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Michelle Minhua Han has held key roles in various tech companies, leading research and development teams to create innovative solutions that have revolutionized industries.

Collaborations: Throughout her career, Michelle Minhua Han has collaborated with top researchers, engineers, and scientists from renowned universities and research institutions worldwide, fostering a culture of innovation and excellence.

Conclusion: Michelle Minhua Han's passion for pushing the boundaries of technology and her relentless drive to innovate have solidified her reputation as a trailblazing inventor in the ever-evolving landscape of technological advancements.

Profile summary based on public USPTO records.